Middle Dose of MRM-3379

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)NCT07209462MIRMPhase 2Recruiting2027-10Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.